Sofie Pattyn, PhD

CTO
ImmunXperts, a Q2 Solutions Company
Gosselies, Hainaut, Belgium

Presentation(s):

• Immunogenicity Risk Assessment: Are Preclinical Methods Informative? (S03)

  Monday, November 18, 2024
  9:00 AM – 12:00 PM CT

• In Vitro Immunogenicity Assessment: Perspective from a CRO (S03-3)

  Monday, November 18, 2024
  9:50 AM – 10:15 AM CT